NLRP3 and neoplasm: For instance, BGL was found to inhibit the release of IL-1β upon NLRP3 inflammasome activation [14], and BGL can also promote the maturation of tumor-educated dendritic cells (TEDCs), which subsequently enhances antitumor immune responses and inhibits tumor progression [15].